Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-21 Sale | 2024-02-22 4:36 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 3,966 | $7.45 | $29,547 | 118,361 (Direct) | View |
2024-02-21 Sale | 2024-02-22 4:34 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 13,033 | $7.46 | $97,226 | 334,954 (Direct) | View |
2024-02-21 Sale | 2024-02-22 4:32 pm | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 3,764 | $7.46 | $28,079 | 175,669 (Direct) | View |
2024-02-20 Sale | 2024-02-22 4:30 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 3,967 | $7.5019 | $29,760 | 87,627 (Direct) | View |
2024-01-17 Sale | 2024-01-19 4:34 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 2,543 | $7.15 | $18,182 | 72,327 (Direct) | View |
2024-01-17 Sale | 2024-01-19 4:32 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 1,266 | $7.18 | $9,090 | 53,094 (Direct) | View |
2023-10-03 Sale | 2023-10-05 4:41 pm | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 13,567 | $6.99 | $94,833 | 149,433 (Direct) | View |
2023-09-15 Sale | 2023-09-18 4:44 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 10,500 | $8.16 | $85,680 | 94,360 (Direct) | View |
2023-07-06 Sale | 2023-07-10 4:42 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,500 | $10.8 | $59,400 | 59,860 (Direct) | View |
2023-06-30 Sale | 2023-07-05 4:32 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $11.41 | $57,050 | 110,360 (Direct) | View |
2023-04-03 Sale | 2023-04-05 5:04 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 7,437 | $7.83 | $58,232 | 214,618 (Direct) | View |
2023-04-03 Sale | 2023-04-05 5:02 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 1,259 | $7.83 | $9,858 | 71,617 (Direct) | View |
2023-03-20 Sale | 2023-03-22 4:49 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 2,193 | $7.76 | $17,018 | 65,360 (Direct) | View |
2023-03-20 Sale | 2023-03-22 4:48 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 3,654 | $7.76 | $28,355 | 72,876 (Direct) | View |
2023-03-20 Sale | 2023-03-22 4:47 pm | Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel | 4,410 | $7.76 | $34,222 | 102,200 (Direct) | View |
2023-03-15 Sale | 2023-03-17 4:37 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 15,373 | $8.2 | $126,059 | 76,530 (Direct) | View |
2023-02-23 Purchase | 2023-02-24 06:15 am | Voyager Therapeutics Inc. | VYGR | NEUROCRINE BIOSCIENCES INC 10% Owner | 4,395,588 | $8.88 | $39,032,821 | 8,575,316 (Direct) | View |
2023-02-17 Sale | 2023-02-22 8:58 pm | Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel | 3,297 | $7.45 | $24,563 | 106,610 (Direct) | View |
2023-02-17 Sale | 2023-02-22 8:57 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 738 | $7.45 | $5,498 | 135,553 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-09 Option Award | 2024-02-16 5:06 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 93,000 | $0 | 154,000 (Direct) | View |
2024-02-09 Option Award | 2024-02-16 5:04 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 115,500 | $0 | 168,594 (Direct) | View |
2024-02-09 Option Award | 2024-02-16 5:03 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 150,000 | $0 | 222,327 (Direct) | View |
2024-02-09 Option Award | 2024-02-16 4:59 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 390,000 | $0 | 607,987 (Direct) | View |
2024-02-09 Option Award | 2024-02-16 4:58 pm | N/A 2034-02-09 | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 90,000 | $0 | 239,433 (Direct) | View |
2023-10-01 Option Award | 2023-10-02 4:24 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 61,000 | $0 | 61,000 (Direct) | View |
2023-09-15 Exercise | 2023-09-18 4:44 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $2.85 | 94,360 (Direct) | View |
2023-09-15 Exercise | 2023-09-18 4:44 pm | N/A 2032-01-13 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $0 | 94,360 (Direct) | View |
2023-07-10 Option Award | 2023-07-11 4:46 pm | N/A 2033-07-10 | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 122,000 | $0 | 122,000 (Direct) | View |
2023-06-30 Exercise | 2023-07-05 4:32 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $2.85 | 110,360 (Direct) | View |
2023-06-30 Exercise | 2023-07-05 4:32 pm | N/A 2032-01-13 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $0 | 110,360 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:41 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:40 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | MACKEY CATHERINE J Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:40 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:39 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:38 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:37 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Colon Grace Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:36 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:35 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-07 4:34 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Hyman Steven Director | 22,000 | $0 | 22,000 (Direct) | View |
2023-05-09 Option Award | 2023-05-11 5:15 pm | N/A 2033-05-09 | Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director | 44,000 | $0 | 44,000 (Direct) | View |
2023-02-23 Option Award | 2023-02-27 5:19 pm | N/A 2033-02-23 | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 44,000 | $0 | 44,000 (Direct) | View |
Ownership | 2023-02-27 5:16 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 0 | $0 | 2,910 (Direct) | View |
2023-02-17 Option Award | 2023-02-22 8:57 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 102,000 | $0 | 135,553 (Direct) | View |